Peijia Medical Limited (HKG:9996)
Hong Kong · Delayed Price · Currency is HKD 5.75
+0.04 (0.70%)
Oct 31, 2025, 9:44 AM HKT
Peijia Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -225.18 | -226.58 | -392.53 | -407.81 | -574.22 | -2,069 | Upgrade |
Depreciation & Amortization | 65.53 | 56.87 | 40.2 | 33.98 | 26.33 | 19.08 | Upgrade |
Other Amortization | 1.61 | 1.45 | 2.61 | 2.03 | 1.15 | 0.4 | Upgrade |
Loss (Gain) From Sale of Assets | -0.01 | 0.37 | 0.22 | 0.03 | 0.22 | 0.38 | Upgrade |
Loss (Gain) From Sale of Investments | 16.98 | 14.98 | -4.05 | -0.58 | -0.68 | -3.7 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | 0.17 | - | - | Upgrade |
Stock-Based Compensation | 11.76 | 10.12 | 28.25 | 27.95 | 30.93 | 36.66 | Upgrade |
Other Operating Activities | -6.28 | -21.37 | -31.29 | -100.47 | 65.89 | 1,895 | Upgrade |
Change in Inventory | 15.33 | 24.66 | -44.47 | -63.06 | -40.82 | -14.12 | Upgrade |
Change in Accounts Payable | 87.1 | 94.7 | -258.97 | 193.53 | 79.36 | -10.42 | Upgrade |
Change in Unearned Revenue | - | - | - | 0.35 | -1.91 | -0.31 | Upgrade |
Change in Other Net Operating Assets | 86.86 | 39.62 | 29.11 | -62.32 | -22.62 | -35.15 | Upgrade |
Operating Cash Flow | 53.69 | -5.18 | -630.91 | -376.2 | -436.37 | -181.1 | Upgrade |
Capital Expenditures | -362.21 | -249.14 | -175.62 | -130.41 | -69.74 | -25.25 | Upgrade |
Sale of Property, Plant & Equipment | 0.33 | - | 0.25 | 0.06 | 0.01 | 0.02 | Upgrade |
Sale (Purchase) of Intangibles | -41.67 | -30.97 | -140.56 | -71.93 | -123.3 | -0.7 | Upgrade |
Investment in Securities | 123.33 | 100.86 | -42.98 | -244.08 | -224.11 | 11.74 | Upgrade |
Other Investing Activities | 29.91 | 38.87 | 20.21 | -16.92 | -7.62 | 1.71 | Upgrade |
Investing Cash Flow | -250.31 | -140.38 | -338.7 | -463.28 | -424.76 | -12.48 | Upgrade |
Long-Term Debt Issued | - | 53 | 146.48 | 126.69 | - | - | Upgrade |
Total Debt Issued | 112 | 53 | 146.48 | 126.69 | - | - | Upgrade |
Long-Term Debt Repaid | - | -25.54 | -59.41 | -3.37 | -3.16 | -1.92 | Upgrade |
Total Debt Repaid | -47.93 | -25.54 | -59.41 | -3.37 | -3.16 | -1.92 | Upgrade |
Net Debt Issued (Repaid) | 64.07 | 27.46 | 87.07 | 123.32 | -3.16 | -1.92 | Upgrade |
Issuance of Common Stock | 2.72 | - | 4.05 | 2.11 | 813.93 | 2,376 | Upgrade |
Repurchase of Common Stock | - | -26.69 | - | -5.18 | -64.72 | -24.75 | Upgrade |
Other Financing Activities | 25.89 | 9.6 | -6.18 | -2.81 | -4.07 | -6.8 | Upgrade |
Financing Cash Flow | 92.68 | 10.38 | 84.95 | 117.44 | 741.98 | 2,342 | Upgrade |
Foreign Exchange Rate Adjustments | 0.19 | 6.15 | 10.77 | 95.59 | -42.91 | -194.99 | Upgrade |
Net Cash Flow | -99.56 | -129.03 | -873.9 | -626.45 | -162.05 | 1,954 | Upgrade |
Free Cash Flow | -308.53 | -254.32 | -806.54 | -506.61 | -506.11 | -206.35 | Upgrade |
Free Cash Flow Margin | -46.21% | -41.32% | -182.84% | -201.97% | -370.68% | -533.84% | Upgrade |
Free Cash Flow Per Share | -0.47 | -0.38 | -1.19 | -0.75 | -0.77 | -0.44 | Upgrade |
Cash Interest Paid | 14.56 | 8.9 | 6.18 | 3.12 | 0.19 | 2.39 | Upgrade |
Cash Income Tax Paid | 12.36 | 7.92 | 3.44 | 9.57 | - | - | Upgrade |
Levered Free Cash Flow | -300.86 | -125.29 | -861.09 | -73.89 | -250.08 | -157.37 | Upgrade |
Unlevered Free Cash Flow | -294.35 | -122.33 | -860.98 | -72.45 | -249.96 | -157.31 | Upgrade |
Change in Working Capital | 189.28 | 158.97 | -274.32 | 68.5 | 14.01 | -60 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.